POST Online Media Lite Edition


Germany grants BioNTech, CureVac $745 million to speed up coronavirus vaccine work

Christian Fernsby |
Germany awarded $745 million in funding to BioNTech and CureVac on Tuesday to speed up work on coronavirus vaccines and expand German production capacity.


esearch Minister Anja Karliczek stressed that safety should remain the utmost priority to ensure vaccines will be accepted by the broader population.

“Even when the world is waiting for a vaccine we won’t take risky short cuts here,” she told a news conference in Berlin.

Karliczek said she does not expect a vaccine to be available for the broader population until the middle of 2021.

What to read next

Sanofi and BioNTech in multiyear exclusive agreement
EU concludes exploratory talks with CureVac to buy potential coronavirus vaccine
German vaccine developer CureVac to receive 75 million euros EU loan